Under down under : the dug-out town of Coober PedyMANN, W. A.Landscape. 1986, Vol 29, Num 2, pp 40-47Article

Apolipoprotein E-1^Harrisburg: a new variant of apolipoprotein E dominantly associated with type III hyperlipoproteinemiaMANN, W. A; GREGG, R. E; SPRECHER, D. L et al.Biochimica et biophysica acta. 1989, Vol 1005, Num 3, pp 239-244, issn 0006-3002Article

Association between the P12A and cl431t polymorphisms in the peroxisome proliferator activated receptor γ (PPARγ) gene and type 2 diabetesEVANS, D; DE HEER, J; HAGEMANN, C et al.Experimental and clinical endocrinology & diabetes. 2001, Vol 109, Num 3, pp 151-154, issn 0947-7349Article

Apolipoprotein E and lipoprotein lipase co-ordinately enhance binding and uptake of chylomicrons by human hepatocytesMANN, W. A; MEYER, N; WEBER, W et al.European journal of clinical investigation. 1995, Vol 25, Num 11, pp 880-882, issn 0014-2972Article

Synthesis and evaluation of non-catechol D-1 and D-2 dopamine receptor agonists: benzimidazol-2-one, benzoxazol-2-one, and the highly potent benzothiazol-2-one 7-ethylaminesWEINSTOCK, J; GAITANOPOULOS, D. E; STRINGER, O. D et al.Journal of medicinal chemistry (Print). 1987, Vol 30, Num 7, pp 1166-1176, issn 0022-2623Article

A polymorphism, L162V, in the peroxisome proliferator-activated receptor a (PPARα) gene is associated with lower body mass index in patients with non-insulin-dependent diabetes mellitusEVANS, D; ABERLE, J; WENDT, D et al.Journal of molecular medicine (Berlin. Print). 2001, Vol 79, Num 4, pp 198-204, issn 0946-2716Article

Frequency of and interaction between polymorphisms in the β3-adrenergic receptor and in uncoupling proteins 1 and 2 and obesity in GermansEVANS, D; MINOUCHEHR, S; HAGEMANN, G et al.International journal of obesity. 2000, Vol 24, Num 10, pp 1239-1245, issn 0307-0565Article

Apolipoprotein E2 (Arg-136→Cys), a variant of apolipoprotein E associated with late-onset dominance of type III hyperlipoproteinaemiaFEUSSNER, G; ALBANESE, M; MANN, W. A et al.European journal of clinical investigation. 1996, Vol 26, Num 1, pp 13-23, issn 0014-2972Article

Mechanism of action and structural requirements of vasopressin analog inhibition of transepithelial water flux in toad urinary bladderMANN, W. A; STASSEN, F; HUFFMAN, W et al.The Journal of pharmacology and experimental therapeutics. 1986, Vol 238, Num 2, pp 401-406, issn 0022-3565Article

Expression of type III hyperlipoproteinemia in patients homozygous for apolipoprotein E-2 is modulated by lipoprotein lipase and postprandial hyperinsulinemiaBRÜMMER, D; EVANS, D; BERG, D et al.Journal of molecular medicine (Berlin. Print). 1998, Vol 76, Num 5, pp 355-364, issn 0946-2716Article

Characterization of maximal intravenous dose volumes in the dog (Canis familiaris)MANN, W. A; KINTER, L. B.General pharmacology. 1993, Vol 24, Num 2, pp 357-366, issn 0306-3623Article

Characterization of the renal handling of p-aminohippurate (PAH) in the beagle dog (Canis familiaris)MANN, W. A; KINTER, L. B.General pharmacology. 1993, Vol 24, Num 2, pp 367-372, issn 0306-3623Article

Determination of pion intranuclear rescattering rates in ν_μ-Ne versus ν_μ-D interactions for the atmospheric ν fluxMERENYI, R; MANN, W. A; KAFKA, T et al.Physical review. D. Particles and fields. 1992, Vol 45, Num 3, pp 743-751, issn 0556-2821Article

Severe hyperlipidemia due to multiple factors in a child with nephrotic syndromeONGKINGCO, J. R. C; MANN, W. A; RULEY, E. J et al.Child nephrology and urology. 1991, Vol 11, Num 2, pp 107-110, issn 1012-6694Article